798 related articles for article (PubMed ID: 9794722)
1. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
3. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
Chen YF; Jin HK; Paul R; Nagahama S
J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
[TBL] [Abstract][Full Text] [Related]
4. Central losartan blocks natriuretic, vasopressin, and pressor responses to central hypertonic NaCl in sheep.
Mathai ML; Evered MD; McKinley MJ
Am J Physiol; 1998 Aug; 275(2):R548-54. PubMed ID: 9688692
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
[TBL] [Abstract][Full Text] [Related]
6. Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension.
Nishimura M; Ohtsuka K; Takahashi H; Yoshimura M
Hypertension; 2000 Jan; 35(1 Pt 2):443-50. PubMed ID: 10642339
[TBL] [Abstract][Full Text] [Related]
7. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
8. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
O'Donaughy TL; Qi Y; Brooks VL
Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
[TBL] [Abstract][Full Text] [Related]
9. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
[TBL] [Abstract][Full Text] [Related]
10. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
Wang H; Wilson N; McNeill JR
Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
[TBL] [Abstract][Full Text] [Related]
11. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
Morton JJ; Garcia del Rio C; Hughes MJ
Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
[TBL] [Abstract][Full Text] [Related]
13. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
Park CG; Leenen FH
J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522
[TBL] [Abstract][Full Text] [Related]
14. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
15. Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats.
Teruya H; Muratani H; Takishita S; Sesoko S; Matayoshi R; Fukiyama K
J Hypertens; 1995 Aug; 13(8):883-90. PubMed ID: 8557966
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Brown L; Duce B; Miric G; Sernia C
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
[TBL] [Abstract][Full Text] [Related]
17. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
[TBL] [Abstract][Full Text] [Related]
18. Role of endothelin and vasopressin in DOCA-salt hypertension.
Yu M; Gopalakrishnan V; McNeill JR
Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
[TBL] [Abstract][Full Text] [Related]
19. Benzamil blockade of brain Na+ channels averts Na(+)-induced hypertension in rats.
Nishimura M; Ohtsuka K; Nanbu A; Takahashi H; Yoshimura M
Am J Physiol; 1998 Mar; 274(3):R635-44. PubMed ID: 9530228
[TBL] [Abstract][Full Text] [Related]
20. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
